Home › Exocrine Pancreatic Insufficiency › California › Los Angeles
Exocrine Pancreatic Insufficiency clinical trials in Los Angeles, CA
3 studies for Exocrine Pancreatic Insufficiency are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
RecruitingPhase 2
- Keck Hospital of USC, Los Angeles
- Cedars Sinai Medical Center - Inflammatory Bowel Disease Ctr, Los Angeles
Phase 2 Study to Assess the Safety and Efficacy of ANG003
RecruitingPhase 2
- Center for Cystic Fibrosis at Keck Medical Center of USC, Los Angeles
Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
RecruitingPhase 4
- University of Southern California, Los Angeles
Exocrine Pancreatic Insufficiency trials in other cities
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.